In a phase 2, randomized, double-blind, placebo-controlled trial of 10 g RM-131 involving 204 patients with diabetic gastroparesis (12% type 1 diabetes mellitus, 88% type 2 diabetes mellitus), with a 28-day treatment period after a 1-week, single-blinded, placebo run-in, RM-131 enhanced gastric emptying and reduced vomiting episodes and vomiting severity
If rapid appetite suppression is your goal, semaglutide is more effective
doi: 10.1016/j.yrtph.2020.104665
Will my insurance cover telemedicine weight loss? Insurance coverage varies widely
Whether it's Ozempic or Wegovy, each pen has a printed expiration date on the box and the pen itself , and that date matters
The platform itself is described in its own terms of use as a technology and administrative services provider rather than a medical practice